Target intelligence / Profile preview

Gastric defense enzymes

01

Overview

Gastric defense enzymes" is not a standard molecular target or specific entity in biomedical science. The term appears to be a non-canonical and overly broad descriptor, combining multiple unrelated protective mechanisms and enzymes found in the gastric environment. The **gastric mucosa**—the lining of the stomach—employs several defense mechanisms to protect itself from autodigestion and injury by gastric acid and digestive enzymes. This defense system consists of multiple components, including: - **Gastric mucus:** Secreted by mucous cells, it forms a protective layer that traps bicarbonate and neutralizes acid at the mucosal surface[1][5]. - **Bicarbonate secretion:** Neutralizes acid that penetrates the mucus layer, maintaining a near-neutral pH at the epithelial surface[1][5]. - **Gastric epithelial cells:** Provide a physical barrier and secrete mucus, playing a key role in defense[1]. - **Prostaglandins:** These hormonelike substances promote mucus and bicarbonate secretion, inhibit acid production, and support mucosal blood flow, contributing to cytoprotection[1][5]. - **Blood flow:** Adequate vascular supply is critical to provide nutrients and remove toxic metabolic products, supporting mucosal integrity[1]. As for **digestive enzymes in the stomach** (collectively referred to as "gastric enzymes"), these primarily include: - **Pepsin:** The main proteolytic enzyme, secreted as pepsinogen and activated by gastric acid[3][7]. - **Gastric lipase:** Breaks down fats, particularly important in infants[7]. - **Gastric amylase:** Minor role in starch digestion, more limited activity compared to pancreatic amylase[7]. - **Gelatinase and renin (chymosin):** Involved in protein and milk protein digestion, respectively, especially in infants[7]. None of these enzymes are individually called "gastric defense enzymes," and their roles in defense are indirect (by supporting digestion rather than direct mucosal protection)[3][7]. Drugs such as **omeprazole** and **lansoprazole** target the proton pump (H⁺/K⁺-ATPase) in gastric parietal cells to reduce acid secretion and are relevant in the therapeutic management of gastric injury and ulcers, not in targeting "gastric defense enzymes"[5]. In summary, "gastric defense enzymes" is not a precise molecular target but rather an inaccurate umbrella term covering both gastric protective mechanisms and digestive enzymes, which are distinct entities[1][5][7].

Beyond the preview

Go deeper on Gastric defense enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric defense enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call